Marginal cost

Clearday’s 2022 Year to Date Update

Retrieved on: 
Monday, November 21, 2022
Innovation, Environment, Perception, AHA, Veteran, Communication, Food, Caregiver, COVID-19, OTCQX, Nursing, Nursing home, Software as a service, ABC7, COVID, Love, Congress, THA, Quality of life, Home, Marginal cost, Hospital

Despite these challenges, Cleardays communities increased their revenues by approximately 2.2% and reduced their operating loss by more than 29%.

Key Points: 
  • Despite these challenges, Cleardays communities increased their revenues by approximately 2.2% and reduced their operating loss by more than 29%.
  • The residential care sector challenges include the Great Resignation which accelerated the caregiver and nursing staff shortage since COVID.
  • ABC7 (Chicago) reported projections that the nursing shortage could reach over 1 million by year end 2022.
  • These forward-looking statements should not be relied upon as representing Cleardays views as of any date subsequent to the date hereof.

Blue Star Foods Reports Growth of 28% to $10.7 Million Revenue for the Nine Months Ended September 30, 2022

Retrieved on: 
Tuesday, November 15, 2022
Blue star, Operating cost, EBITDA, ESG, Engineering, BSFC, RAS, National Food Security Act, 2013, Total, Nine Months, Soft-shell crab, Security (finance), Callinectes sapidus, Biophysical environment, Depreciation, Marginal cost, Recirculating aquaculture system, Salmon, Three Months in the Southern States, Renewable energy, Aquaculture, Social

Miami, FL, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (“ESG”) sustainable seafood company with a focus on Recirculatory Aquaculture Systems (“RAS”), announced financial and operational results for the three and nine months ended September 30, 2022.

Key Points: 
  • Operating loss for the three months ended September 30, 2022, increased by $2.9 million, to $3.4 million, compared to $0.5 million for the three months ended September 30, 2021.
  • Net loss for the three months ended September 30, 2022, increased by $3.5 million, to $3.7 million, compared to $0.2 million for the three months ended September 30, 2021.
  • Operating loss for the nine months ended September 30, 2022, increased by $4.0 million, to $5.3 million, compared to $1.3 million for the nine months ended September 30, 2021.
  • Net loss for the nine months ended September 30, 2022, increased by $5.2 million to $6.2 million, compared to $1.1 million for the nine months ended September 30, 2021
    Adjusted EBITDA loss for the nine months ended September 30, 2022, increased by $1.9 million, to $2.3 million, compared to $0.4 million for the nine months ended September 30, 2021.

POET Technologies Reports Third Quarter 2022 Financial Results

Retrieved on: 
Monday, November 14, 2022
Growth, Selective laser sintering, Programmable interrupt controller, FR4, Special, PTK, NRE, Suretrack Contracts Services, Optics, SEDAR, CIOE, Laser, POET, Octal, Die (integrated circuit), Blockchain.com, Artificial intelligence, TIA, Research, Depreciation, Celestial, Marginal cost, Loss, Light, Renewable energy, Lithium, Video game

TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- POET Technologies Inc. (POET or the Company) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today reported its unaudited condensed consolidated financial results for the third quarter ended September 30, 2022.

Key Points: 
  • TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- POET Technologies Inc. (POET or the Company) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer, Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today reported its unaudited condensed consolidated financial results for the third quarter ended September 30, 2022.
  • The Company had finance costs of $12,000 in the third quarter of 2022 compared to $20,000 in the third quarter of 2021 and $13,000 in the second quarter of 2022.
  • Cash flow from operating activities in the third quarter of 2022 was ($2.5) million compared to ($2.8) million in the third quarter of 2021 and ($3.3) million in the second quarter of 2022.
  • These non-IFRS financial performance measures are included because management has used the information to analyze the business performance and financial position of POET.

Miromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update

Retrieved on: 
Monday, November 14, 2022
Operating cost, ASN, HHS, American Society of Nephrology, Event, IND, Partnership, EDEN, Patient, IPO, Annual report, Office of Inspector General, U.S. Department of Health and Human Services, Maintenance, Society, Security (finance), Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, MIRO, Form 8-K, Research, Marginal cost, Coronavirus, Clinical trial, Investment, FDA, Pharmaceutical industry

"Miromatrix is excited to announce that we recently submitted our IND for miroliverELAP," said Jeff Ross, Ph.D., Miromatrix CEO.

Key Points: 
  • "Miromatrix is excited to announce that we recently submitted our IND for miroliverELAP," said Jeff Ross, Ph.D., Miromatrix CEO.
  • "We believe this is the first IND to be submitted to the FDA for a bioengineered organ.
  • The Company will host a live conference call and webcast to discuss these results and provide a corporate update on Monday, November 14, 2022, at 4:30 PM ET.
  • The foregoing sets forth many, but not all, of the factorsthat could cause actual results to differ from ourexpectations in any forward-looking statement.

mdf commerce reports Second Quarter of Fiscal 2023 Financial Results

Retrieved on: 
Monday, November 14, 2022
Sale, Naftiran Intertrade, R, Marketing, Total, Financial assistance (share purchase), Marginal cost, Adjustment, International, TSX, Commerce, Corporation, Acquisition, Software as a service, Supply chain collaboration, Asset, EBITDA, Growth, International Financial Reporting Standards, SPS Commerce, Net, Video game, Bank, Tutoring, Mobile phone, Reinsurance, Periscope

This quarter marks a return to positive Adjusted EBITDA(2) achieved through a combination of growth and operational efficiency efforts.

Key Points: 
  • This quarter marks a return to positive Adjusted EBITDA(2) achieved through a combination of growth and operational efficiency efforts.
  • The total purchase consideration was $65.8 million(3) (US$48.5 million) or approximately 5X Revenue(4), subject to certain post-closing adjustments", said Luc Filiatreault, CEO of mdf commerce.
  • Total revenues for Q2 FY2023 reached $33.2 million, an increase of $8.1 million or 32.4% compared to $25.1 million reported in Q2 FY2022.
  • Our two core platforms, eprocurement and Unified Commerce contributed to revenues of the second quarter as follows:
    The eprocurement platform generated revenues of $19.3 million, an increase of $8.0 million or 71.2% compared to $11.3 million in Q2 FY2022.

Culp Announces Revised Expectations, Including Impairment and Markdowns of Inventory, and Improved Cash Position for Second Quarter Fiscal 2023

Retrieved on: 
Tuesday, November 22, 2022
Home Goods, Other Manufacturing, Textiles, Specialty, Consumer, Other Consumer, Manufacturing, Retail, An Act to exempt a particular class of securities from the Securities and Exchange Act, Investment, Weakness, Sale, SG, Marginal cost, Form, NYSE, Loss, Policy, Housing, Acquisition, Security (finance), Form 10-K, Rationalization, Public expenditure, Retail, Bank

The company also expects to end the quarter with a higher cash position than the first quarter of fiscal 2023, with approximately $19 million in cash and investments and no outstanding borrowings.

Key Points: 
  • The company also expects to end the quarter with a higher cash position than the first quarter of fiscal 2023, with approximately $19 million in cash and investments and no outstanding borrowings.
  • Commenting on the announcement, Iv Culp, president and chief executive officer of Culp, Inc., said, The revised expectations for the second quarter of fiscal 2023 reflect continued demand weakness, particularly for our mattress fabrics segment, along with inventory impacts within both segments.
  • While these decisions will result in a higher operating loss for the second quarter, we believe having the financial impact behind us will position us for improvement during the second half of fiscal 2023.
  • The company expects to report financial and operating results for the second quarter of fiscal 2023 in early December.

AM Best Withdraws Credit Ratings of Center Mutual Insurance Company

Retrieved on: 
Thursday, November 17, 2022
Insurance, Professional Services, News, Credit, Marginal cost, ALL, Weather, Insurance, AM Best, AM, Risk management

AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) of a- (Excellent) of Center Mutual Insurance Company (Center Mutual) (Rugby, ND).

Key Points: 
  • AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) of a- (Excellent) of Center Mutual Insurance Company (Center Mutual) (Rugby, ND).
  • Concurrently, AM Best has withdrawn these ratings as the company has requested to no longer participate in AM Bests interactive rating process.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

SunLink Health Systems, Inc. Announces Fiscal 2023 First Quarter and COVID-19 Update

Retrieved on: 
Tuesday, November 15, 2022
Hospitals, Health, Practice Management, Nursing, Managed Care, Forgiveness, CMS, Calendar, Nursing, Quarantine, PRF, World Health Organization, File, Government, CARES Act, Marginal cost, SunLink, NYSE, Small business, Health care, ERC, Vaccination, Health Resources and Services Administration, PPP, Security (finance), Nature, DME, HHS, Small Business Administration, Death, The Rehabilitation Center at Hollywood Hills, Legislation, Risk, Public expenditure, Patient, Pension fund, Pharmaceutical industry, Health insurance, Pharmacy, COVID-19

The fiscal quarter ended September 30, 2021 included forgiveness of Paycheck Protection Plan (PPP) loans of $3,010,000 (pre-tax) which did not reoccur in the fiscal quarter ended September 30, 2022.

Key Points: 
  • The fiscal quarter ended September 30, 2021 included forgiveness of Paycheck Protection Plan (PPP) loans of $3,010,000 (pre-tax) which did not reoccur in the fiscal quarter ended September 30, 2022.
  • SunLink reported an operating loss for the quarter ended September 30, 2022 of $1,613,000 compared to an operating loss for the quarter ended September 30, 2021 of $993,000.
  • SunLink Health Systems, Inc. is the parent company of subsidiaries that own and operate healthcare properties and businesses in the Southeast.
  • For additional information on SunLink Health Systems, Inc., please visit the Companys website.

CHICKEN SOUP FOR THE SOUL ENTERTAINMENT REPORTS Q3 2022 RESULTS

Retrieved on: 
Monday, November 14, 2022
Other Entertainment, General Entertainment, Entertainment, Books, AVOD, Investment, TVOD, Marketing, Conversation, Result, GAAP, Chicken Soup for the Soul, Analysis, Operation, Publicis, Crackle, Partnership, Risk, Marginal cost, Adjustment, FuboTV, Popcornflix, FAST, Financial condition report, Acquisition, Regulate... G Funk Era, Depreciation, Nature, Forecasting, DVD, Soup, EBITDA, Ecosystem, Growth, Regulation, History, Tax, Video game, Bank, Chicken soup, Redbox

Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE), one of the largest providers of premium content to value-conscious consumers, today announced its financial results for the third quarter ended September 30, 2022.

Key Points: 
  • Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE), one of the largest providers of premium content to value-conscious consumers, today announced its financial results for the third quarter ended September 30, 2022.
  • The company also appointed Jason Meier as the Chief Financial Officer of Chicken Soup for the Soul Entertainment effective November 15, 2022.
  • Chris Mitchell will continue as the Chief Financial Officer of the parent company, Chicken Soup for the Soul Holdings and will remain a member of the Board of Directors of Chicken Soup for the Soul Entertainment.
  • Chicken Soup for the Soul Entertainment is a subsidiary of Chicken Soup for the Soul, LLC, which publishes the famous book series and produces super-premium pet food under the Chicken Soup for the Soul brand name.

Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, November 15, 2022
Adult, Chest pain, Cancer, Gulf Cooperation Council, Pain, Expense, U.S. Securities and Exchange Commission, Security (finance), Back pain, Constipation, Splenomegaly, Abdominal pain, Cough, Safety, United Kingdom, Sickle cell disease, United Arab Emirates, Company, Indigestion, Time, Marketing, Research, IRAK4, Annual report, Emma Walmsley, Private Securities Litigation Reform Act, Patient, Ministry, Operating cost, Incidence, Net, Headache, GCC, Marginal cost, Extremities, Food, Kingdom, Regulation of tobacco by the U.S. Food and Drug Administration, OTCQX, Nausea, Pharmaceutical industry, Income, Health, Q3, Glutamine

TORRANCE, Calif., Nov. 14, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA),a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its results of operations and financial condition as of and for the three and nine months ended September30, 2022 and provided a business update.

Key Points: 
  • TORRANCE, Calif., Nov. 14, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA),a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its results of operations and financial condition as of and for the three and nine months ended September30, 2022 and provided a business update.
  • Net revenues in Q3 2022 increased by $0.7 million, or nearly 15%, from Q2 2022 net revenues of $4.3 million.
  • Total operating expenses in Q3 2022 decreased slightly from Q2 2022 due to $0.3 million decrease in selling expenses.
  • Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease.